E6

Pembina Pipeline Corporation Reports Record Results for the Fourth Quarter 2023, Provides Business Update, and Declares Quarterly Common Share Dividend

Retrieved on: 
Thursday, February 22, 2024

Pembina reported record quarterly adjusted EBITDA of $1,033 million in the fourth quarter and record full year adjusted EBITDA of $3,824 million.

Key Points: 
  • Pembina reported record quarterly adjusted EBITDA of $1,033 million in the fourth quarter and record full year adjusted EBITDA of $3,824 million.
  • Results were impacted by higher incentive costs driven by Pembina's share price performance and increased shared service revenue.
  • On a per share (basic) basis, cash flow from operating activities was $1.60 per share for the fourth quarter and $4.79 per share for the full year.
  • ET) for interested investors, analysts, brokers and media representatives to discuss results for the fourth quarter of 2023.

Kanazawa University research: Researchers observe what ubiquitination hinges on

Retrieved on: 
Wednesday, January 10, 2024

KANAZAWA, Japan, Jan. 10, 2024 /PRNewswire/ -- Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University report in Nano Letters how the flexibility of a protein hinge plays a crucial role in the transfer of proteins in key cell processes.

Key Points: 
  • KANAZAWA, Japan, Jan. 10, 2024 /PRNewswire/ -- Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University report in Nano Letters how the flexibility of a protein hinge plays a crucial role in the transfer of proteins in key cell processes.
  • Ubiquitination – the addition of the protein ubiquitin - is a key stage in many cell processes, such as protein degradation, DNA repairs, and signal transduction.
  • Using high-speed atomic force microscopy (HS-AFM) and molecular modelling, researchers led by Hiroki Konno and Holger Flechsig at WPI-NanoLSI, Kanazawa University have identified how the mobility of a ubiquitination related enzyme hinge allows ubiquitination to take place.
  • In the 2000s Toshio Ando at Kanazawa University was able to improve the scanning speed to such an extent that moving images could be captured.

Kanazawa University research: Researchers observe what ubiquitination hinges on

Retrieved on: 
Wednesday, January 10, 2024

KANAZAWA, Japan, Jan. 10, 2024 /PRNewswire/ -- Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University report in Nano Letters how the flexibility of a protein hinge plays a crucial role in the transfer of proteins in key cell processes.

Key Points: 
  • KANAZAWA, Japan, Jan. 10, 2024 /PRNewswire/ -- Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University report in Nano Letters how the flexibility of a protein hinge plays a crucial role in the transfer of proteins in key cell processes.
  • Ubiquitination – the addition of the protein ubiquitin - is a key stage in many cell processes, such as protein degradation, DNA repairs, and signal transduction.
  • Using high-speed atomic force microscopy (HS-AFM) and molecular modelling, researchers led by Hiroki Konno and Holger Flechsig at WPI-NanoLSI, Kanazawa University have identified how the mobility of a ubiquitination related enzyme hinge allows ubiquitination to take place.
  • In the 2000s Toshio Ando at Kanazawa University was able to improve the scanning speed to such an extent that moving images could be captured.

Michigan-Based Photo Systems Inc. Announces Brand Licensing Agreement for Kodak Professional Photographic Chemicals, Full Range Launching in Early 2024

Retrieved on: 
Thursday, December 7, 2023

DEXTER, Mich., Dec. 7, 2023 , Dec. 7, 2023 -- Consumers are set to see Kodak branded photo chemicals widely available in early 2024. Photo Systems, Inc, a new authorized brand licensee, will begin manufacturing in the U.S. early next year, bringing Kodak Professional Photographic Chemicals to market.

Key Points: 
  • DEXTER, Mich., Dec. 7, 2023 , Dec. 7, 2023 -- Consumers are set to see Kodak branded photo chemicals widely available in early 2024.
  • Photo Systems, Inc, a new authorized brand licensee, will begin manufacturing in the U.S. early next year, bringing Kodak Professional Photographic Chemicals to market.
  • We are pleased to become the licensee of Kodak and carry on the more than 150-year tradition of Kodak Professional Photographic Chemicals."
  • Kodak Professional Photographic Chemicals run the gamut of analog photography, including conventional black and white, C41, E6, and RA4 processes.

Michigan-Based Company Photo Systems Inc. Gets Exclusive Rights for Eastman Kodak Co.; Takes Over as Brand Licensee and Brings Kodak Professional Photographic Chemicals Back into Production in Early 2024

Retrieved on: 
Tuesday, December 5, 2023

DEXTER, Mich., Dec. 5, 2023 /PRNewswire/ -- Consumers are set to see Eastman Kodak branded photo chemicals widely available worldwide in early 2024, thanks to striking a deal with Photo Systems Inc. as its new authorized brand licensee. Kodak Professional Photographic Chemicals will begin being manufactured in the U.S. early next year, bringing the Kodak Professional-branded development chemicals back into production.

Key Points: 
  • Kodak Professional Photographic Chemicals will begin being manufactured in the U.S. early next year, bringing the Kodak Professional-branded development chemicals back into production.
  • However, Photo Systems Inc. stepped in, becoming the new brand licensee for Kodak Professional Photographic Chemicals in September 2023.
  • We are pleased to become the licensee of Eastman Kodak and carry on the more than 150-year tradition of Kodak Professional Photographic Chemicals."
  • Kodak Professional Photographic Chemicals run the gamut of analog photography, including conventional black and white, C41, E6, and RA4 processes.

HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab as First-Line Treatment in Patients with HPV16+ Head and Neck Cancers at European Society for Medical Oncology Congress 2023

Retrieved on: 
Sunday, October 22, 2023

All evaluable patients were alive at the data cutoff (DCO), and the median follow-up time at DCO was 8.3 months.

Key Points: 
  • All evaluable patients were alive at the data cutoff (DCO), and the median follow-up time at DCO was 8.3 months.
  • Importantly, results showed significant activation of antigen-specific CD8+ T cells, the body’s primary driver of tumor killing activity.
  • Out of 17 patients with available peripheral blood mononuclear cells (PMBC) samples, all patients showed an increase of tumor antigen-specific circulating HPV16+ CD8+ T cells.
  • These data represent a doubling of the 19 percent ORR reported for pembrolizumab alone1 and are consistent with previously reported HB-200 data.

Randolph Pointe Offers Niche Military Housing Option

Retrieved on: 
Wednesday, October 18, 2023

Randolph Pointe at Fort Liberty stands as an example of the significance and benefits of such housing for single service members.

Key Points: 
  • Randolph Pointe at Fort Liberty stands as an example of the significance and benefits of such housing for single service members.
  • (Photo: Business Wire)
    In the early days of the United States military, single service members typically lived in basic communal barracks on military installations.
  • At Fort Liberty, Randolph Pointe was born, housing single service members who were no longer eligible for the barracks.
  • Recognizing the importance of such housing is essential in promoting the welfare and readiness of our military forces.

Transgene Advances Its Innovative Immunotherapy Pipeline and Extends Financial Visibility Until the End of 2024

Retrieved on: 
Wednesday, September 20, 2023

We are planning together with our partner NEC to start a randomized Phase II trial in 2024.

Key Points: 
  • We are planning together with our partner NEC to start a randomized Phase II trial in 2024.
  • Transgene and NEC intend to start a randomized Phase II trial in the adjuvant setting of head and neck cancer in 2024.
  • Transgene is assessing all options to ensure data read out in 2024 from the trial as previously communicated.
  • The Board of Directors of Transgene met on September 20, 2023, and approved the financial statements for the six-month period ended June 30, 2023.

Episode Six Launches Business Now, Pay Later™ Enabling Financial Institutions to Offer B2B Installments to Small and Medium-sized Enterprises

Retrieved on: 
Wednesday, September 13, 2023

Episode Six (E6), a leading global provider of enterprise-grade payment processing and ledger infrastructure, today announced the launch of Business Now, Pay Later.

Key Points: 
  • Episode Six (E6), a leading global provider of enterprise-grade payment processing and ledger infrastructure, today announced the launch of Business Now, Pay Later.
  • Business Now, Pay Later directly addresses this need by industrializing the conventional buy now, pay later (BNPL) model, strengthening it and making it fit-for-purpose for commercial banks and their customers.
  • Business Now, Pay Later enables banks to offer installment loans to businesses at any point in their buying journey, including before, during and after payment.
  • We are helping banks do so by providing a turnkey solution to offer tailored installment products directly in their business banking channel.

2024 GEM Redefines Low-Speed Vehicle Industry

Retrieved on: 
Thursday, July 27, 2023

ANAHEIM, Calif., July 26, 2023 /PRNewswire/ -- The 2024 GEM electric vehicles are setting a new standard in the low-speed vehicle (LSV) category. Waev is introducing the new 2024 GEM passenger and utility vehicles with more than 30 modern refinements to expand adoption and provide a more automotive-like driving experience.

Key Points: 
  • New GEM lineup redefines the LSV category with more than 30 automotive-like electric vehicle refinements.
  • ANAHEIM, Calif., July 26, 2023 /PRNewswire/ -- The 2024 GEM electric vehicles are setting a new standard in the low-speed vehicle (LSV) category.
  • New GEM lineup redefines the LSV category with more than 30 automotive-like electric vehicle refinements.
  • Through the 2024 EV refinements, GEM maintains its attractive price points – making GEM vehicles appealing and viable alternatives to full-sized electric sedans and trucks.